Clinical Equivalence of a Salmeterol/Fluticasone Propionate Combination Product (50/500??g) Delivered via a Chlorofluorocarbon-Free Metered-Dose Inhaler with the Diskus??? in Patients with Moderate to Severe Asthma
Authors:
- 1 January 2001
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 21 (4) , 243-255
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Salmeterol/fluticasone propionate (50500 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthmaRespiratory Medicine, 1999
- Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus InhalersCanadian Respiratory Journal, 1999
- Salmeterol/Fluticasone Combination InhalerClinical Drug Investigation, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Comparison of Addition of Salmeterol to Inhaled Steroids With Doubling of the Dose of Inhaled SteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Assessing equivalence of inhaled drugsRespiratory Medicine, 1995
- Comparison of DiskusTMInhaler, a New Multidose Powder Inhaler, with DiskhalerTMInhaler for the Delivery of Salmeterol to Asthmatic PatientsJournal of Asthma, 1995
- Metered-dose inhalers and CFCs: what respiratory physicians need to knowRespiratory Medicine, 1994
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994